People · Operator

Harry Thomas Hall, IV

Named in public records as an officer, director or promoter · active 2025–2026 · Medical Devices, Healthtech

2
Companies
4
Filings
$5.4M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Pace Surgical, Inc.Medical DevicesSeed$4.9M$3.4M2025
Crossover Medical, Inc.HealthtechPre-Seed$500K$962K2026
Operator network

Harry Thomas Hall, IV at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

William John Odenthal · 3 companies · 1 sharedWilliam John Oden…Nicholas F. Pachuda · 2 companies · 1 sharedNicholas F. Pachu…Jeffery F. O'Donnell, Jr. · 1 companies · 1 sharedJeffery F. O'Donn…Michael F. West · 1 companies · 1 sharedMichael F. WestMichael Scott West · 1 companies · 1 sharedMichael Scott WestNicholas Scott Pachuda · 1 companies · 1 sharedNicholas Scott Pa…Nicholas Thomas Pachuda · 1 companies · 1 sharedNicholas Thomas P…Jeffrey F. O'Donnell, Sr. · 5 companies · 2 sharedJeffrey F. O'Donn…Jeffrey F. O'Donnell, Jr. · 4 companies · 2 sharedJeffrey F. O'Donn…William Scott Rhoda · 4 companies · 2 sharedWilliam Scott Rho…Pace Surgical, Inc. · $4.9M raisedPace Surgical, Inc.Crossover Medical, Inc. · $0.5M raisedCrossover Medical, In…Harry Thomas Hall, IVHI
Harry Thomas Hall, IV Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Harry Thomas Hall, IV on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jeffrey F. O'Donnell, Sr.25
Jeffrey F. O'Donnell, Jr.24
William Scott Rhoda24
William John Odenthal13
Nicholas F. Pachuda12
Jeffery F. O'Donnell, Jr.11
Michael Scott West11
Nicholas Scott Pachuda11
Michael F. West11
Nicholas Thomas Pachuda11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.